Cargando…

Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions

When plasmonic nanoparticles (NPs) are internalized by cells and agglomerate within intracellular vesicles, their optical spectra can shift and broaden as a result of plasmonic coupling of NPs in close proximity to one another. For such optical changes to be accounted for in the design of plasmonic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Allen L., Jackson, Meredith A., Lin, Adam Y., Figueroa, Elizabeth R., Hu, Ying S., Evans, Emily R., Asthana, Vishwaratn, Young, Joseph K., Drezek, Rebekah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912538/
https://www.ncbi.nlm.nih.gov/pubmed/27316744
http://dx.doi.org/10.1186/s11671-016-1524-4
_version_ 1782438275111190528
author Chen, Allen L.
Jackson, Meredith A.
Lin, Adam Y.
Figueroa, Elizabeth R.
Hu, Ying S.
Evans, Emily R.
Asthana, Vishwaratn
Young, Joseph K.
Drezek, Rebekah A.
author_facet Chen, Allen L.
Jackson, Meredith A.
Lin, Adam Y.
Figueroa, Elizabeth R.
Hu, Ying S.
Evans, Emily R.
Asthana, Vishwaratn
Young, Joseph K.
Drezek, Rebekah A.
author_sort Chen, Allen L.
collection PubMed
description When plasmonic nanoparticles (NPs) are internalized by cells and agglomerate within intracellular vesicles, their optical spectra can shift and broaden as a result of plasmonic coupling of NPs in close proximity to one another. For such optical changes to be accounted for in the design of plasmonic NPs for light-based biomedical applications, quantitative design relationships between designable factors and spectral shifts need to be established. Here we begin building such a framework by investigating how functionalization of gold NPs (AuNPs) with biocompatible poly(ethylene) glycol (PEG), and the serum conditions in which the NPs are introduced to cells impact the optical changes exhibited by NPs in a cellular context. Utilizing darkfield hyperspectral imaging, we find that PEGylation decreases the spectral shifting and spectral broadening experienced by 100 nm AuNPs following uptake by Sk-Br-3 cells, but up to a 33 ± 12 nm shift in the spectral peak wavelength can still occur. The serum protein-containing biological medium also modulates the spectral changes experienced by cell-exposed NPs through the formation of a protein corona on the surface of NPs that mediates NP interactions with cells: PEGylated AuNPs exposed to cells in serum-free conditions experience greater spectral shifts than in serum-containing environments. Moreover, increased concentrations of serum (10, 25, or 50 %) result in the formation of smaller intracellular NP clusters and correspondingly reduced spectral shifts after 5 and 10 h NP-cell exposure. However, after 24 h, NP cluster size and spectral shifts are comparable and become independent of serum concentration. By elucidating the impact of PEGylation and serum concentration on the spectral changes experienced by plasmonic NPs in cells, this study provides a foundation for the optical engineering of plasmonic NPs for use in biomedical environments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s11671-016-1524-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4912538
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-49125382016-07-06 Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions Chen, Allen L. Jackson, Meredith A. Lin, Adam Y. Figueroa, Elizabeth R. Hu, Ying S. Evans, Emily R. Asthana, Vishwaratn Young, Joseph K. Drezek, Rebekah A. Nanoscale Res Lett Nano Express When plasmonic nanoparticles (NPs) are internalized by cells and agglomerate within intracellular vesicles, their optical spectra can shift and broaden as a result of plasmonic coupling of NPs in close proximity to one another. For such optical changes to be accounted for in the design of plasmonic NPs for light-based biomedical applications, quantitative design relationships between designable factors and spectral shifts need to be established. Here we begin building such a framework by investigating how functionalization of gold NPs (AuNPs) with biocompatible poly(ethylene) glycol (PEG), and the serum conditions in which the NPs are introduced to cells impact the optical changes exhibited by NPs in a cellular context. Utilizing darkfield hyperspectral imaging, we find that PEGylation decreases the spectral shifting and spectral broadening experienced by 100 nm AuNPs following uptake by Sk-Br-3 cells, but up to a 33 ± 12 nm shift in the spectral peak wavelength can still occur. The serum protein-containing biological medium also modulates the spectral changes experienced by cell-exposed NPs through the formation of a protein corona on the surface of NPs that mediates NP interactions with cells: PEGylated AuNPs exposed to cells in serum-free conditions experience greater spectral shifts than in serum-containing environments. Moreover, increased concentrations of serum (10, 25, or 50 %) result in the formation of smaller intracellular NP clusters and correspondingly reduced spectral shifts after 5 and 10 h NP-cell exposure. However, after 24 h, NP cluster size and spectral shifts are comparable and become independent of serum concentration. By elucidating the impact of PEGylation and serum concentration on the spectral changes experienced by plasmonic NPs in cells, this study provides a foundation for the optical engineering of plasmonic NPs for use in biomedical environments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s11671-016-1524-4) contains supplementary material, which is available to authorized users. Springer US 2016-06-18 /pmc/articles/PMC4912538/ /pubmed/27316744 http://dx.doi.org/10.1186/s11671-016-1524-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Nano Express
Chen, Allen L.
Jackson, Meredith A.
Lin, Adam Y.
Figueroa, Elizabeth R.
Hu, Ying S.
Evans, Emily R.
Asthana, Vishwaratn
Young, Joseph K.
Drezek, Rebekah A.
Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions
title Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions
title_full Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions
title_fullStr Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions
title_full_unstemmed Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions
title_short Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions
title_sort changes in optical properties of plasmonic nanoparticles in cellular environments are modulated by nanoparticle pegylation and serum conditions
topic Nano Express
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912538/
https://www.ncbi.nlm.nih.gov/pubmed/27316744
http://dx.doi.org/10.1186/s11671-016-1524-4
work_keys_str_mv AT chenallenl changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions
AT jacksonmereditha changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions
AT linadamy changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions
AT figueroaelizabethr changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions
AT huyings changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions
AT evansemilyr changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions
AT asthanavishwaratn changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions
AT youngjosephk changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions
AT drezekrebekaha changesinopticalpropertiesofplasmonicnanoparticlesincellularenvironmentsaremodulatedbynanoparticlepegylationandserumconditions